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Introduction
Cognitive impairment is highly prevalent in those on hemodialysis (HD); up to 70% in an unselected cohort demonstrated cognitive impairment 1 . The aetiology of cognitive impairment in HD is multifactorial: dialysis is associated with profound metabolic abnormalities, chronic inflammation and oxidative and hemodynamic stressors. However, two important findings support the theory that cerebrovascular disease is the primary driving force. Specifically, dialysis preferentially induces deficits in executive function [2] [3] [4] , a pattern traditionally observed early in vascular cognitive impairment but only a later complication of other dementias such as Alzheimer's disease 5 and that more regular frequent dialysis does not improve cognitive function 6 , whereas renal transplantation can 7 .
The frequency of cerebrovascular disease in people with end-stage renal disease (ESRD) is up to 10-fold greater 8 compared to the general population and mortality rates approximately three-fold greater 9 . Although conventional stroke risk factors such as hypertension are ubiquitous in ESRD and partly responsible, it is likely renal specific factors contribute to this inordinate difference. For example, there is increasing evidence that both initiation 10 of and exposure 11, 12 to HD for ESRD is associated with stroke, although the mechanism is not fully explained. Interestingly, this risk appears to be reduced by receiving a renal transplant 13 .
The concept that HD can induce cerebral injury is supported by previous studies.
Two recent prospective European studies have demonstrated evidence of decreased intradialytic cerebral perfusion 14, 15 , relating this to dialysis related factors such as intradialytic hypotension or ultrafiltration volume. Alterations in cerebral structure are also described. For example, white matter hyperintensities (WMH), a marker of small vessel disease, are present incidentally in 11-21% of the general population aged around 64 years 16 whereas this rises to 52% in those on HD 17 . Increasing WMH burden is associated not only with stroke 18 but also cognitive impairment 1 .
Real-time non-invasive measurement of cerebral blood flow is possible using transcranial Doppler (TCD) ultrasound, a non-invasive, inexpensive tool which is well tolerated and capable of performing repeated measurement throughout a dialysis session. Our primary hypothesis is that cerebral blood flow, measured by TCD, is reduced by hemodialysis and correlates with a decline in intradialytic cognitive function. Secondarily, we hypothesize that a reduction in cerebral blood flow is capable of reducing longer term cognitive function, inducing ischemic damage as measured by white matter hyper-intensity (WMH) burden and that progressive ischemia on brain MRI at 12 months will correlate with progressive cognitive decline.
Therefore, we present a prospective investigation of real-time dialysis related cerebral blood flow, cognitive function on and off dialysis and brain MRI findings over a 12-month follow-up of continuous treatment for ESRD.
The primary aim of this study was to explore whether HD was associated with changes in cerebral blood flow and determine whether these changes relate to intradialytic cognitive dysfunction. Our secondary aims focus on (1) assessment of longitudinal changes in cerebral structure and function using brain MR imaging and cognitive assessment at baseline and after 12 months, correlating this to alterations in cerebral blood flow and (2) to compare cognitive outcomes at follow-up in those who remain on hemodialysis and those who receive a renal transplant.
Methods
Recruitment began in April 2015 and the first visit took place on 3 June 2015. All visits were completed by 7 July 2017. Participants were asked to attend three visits over a 12 month follow-up period. Two visits took place within the first month: one during their routine dialysis treatment (intra-dialytic assessment), and a second on a non-dialysis day (inter-dialytic assessment). At 12 months a repeat non-dialysis assessment was performed.
Study participants
All adult patients aged 18-85 inclusive receiving hospital hemodialysis for ESRD at the Glasgow Renal and Transplant unit were considered. We approached all adults who were expected to remain on hospital hemodialysis for ≥ 6months. Exclusion criteria were: inability to consent, poor comprehension of English language, a prior diagnosis or neuroimaging evidence of cerebrovascular disease and prior diagnoses of cognitive impairment. Neuroimaging evidence of cerebrovascular disease included all those with prior ischemic or hemorrhagic stroke in addition to those with evidence of small vessel disease. Written informed consent was completed for each participant. This study was approved following ethical review by the West of Scotland research ethics committee 5, reference REC 15/WS/0024 and registered on ClinicalTrials.gov under identifier NCT02393222.
Clinical Variables
Patient demographics were acquired from the electronic patient record. Duration of ESRD was calculated in years from date of first RRT commencement until date of first visit. Pre-and post-blood pressure and ultrafiltration volumes were recorded and presented as an average of the last 6 readings. Laboratory values utilised the three latest results preceding their first visit. During the intradialytic assessment visit, blood pressure and weight were recorded before and after dialysis, and UF rate calculated as volume of fluid removed divided by duration of session.
Dialysis Schedule
This observational study was designed to assess the effect of dialysis in a 'real- was completely avoided. All Doppler readings were performed with patients sitting upright. It was essential that patients remained comfortable during their cognitive assessments, therefore food and rest periods were permitted.
Cognitive Assessments
Assessments were carried out by medical and nursing staff following training in appropriate use of the assessments by an experienced psychologist. At the midpoint of our study, re-training was performed to ensure consistency of assessment.
Intra-dialytic testing was performed within the first 2 hours of dialysis, omitting the first 15 minutes for initial physiological monitoring and routine nursing checks. All physical assessment as part of routine dialysis was performed manually, by usual dialysis nursing staff. The dialysis unit staff were aware to keep interruption to a minimum and cognitive testing was halted during scheduled blood pressure checks.
Where practically possible, in order to account for environmental effects on cognitive function participants returned to the dialysis unit for their inter-dialytic assessment. Further information on each assessment is described in supplementary table s1. The MOCA was used to quantify 'cognitive impairment', therefore presented as an education adjusted score (addition of 1 for those with 12 year or less education). All other scores are presented as raw, unadjusted data.
In an attempt to blunt possible learning effects, all visits were held a minimal 14 days apart. Further, we used versions 7.1, 7.2 and 7.3 of the MOCA and HVLT 1, 2, 5 and 6 at differing visits throughout the study.
In cases where writing was not possible, for example a participant's inability or unwillingness to move their dominant arm during dialysis (n=9), the MOCA-BLIND method was usedadjusting the cut-off for cognitive impairment <18, and the verbal LDST was performed. 
Image analyses
MR images were analysed using volumetric analyses software. The first step in automated extraction of WMH volumes was to estimate the white matter area in each subject using atlas-based segmentation. A probability map of white matter was previously created from 313 volunteers aged 18-96 years 19 and registered to each subject using non-linear (diffeomorphic) registration to provide an initial estimate of white matter in each subject 20 . Hyperintense outliers were identified on T2 FLAIR by transforming each voxel to a standard (z) score 21 . Voxels with z≥1.5 and within the estimated white matter area were initially defined as WMH. Final WMH estimates were defined by 3D Gaussian smoothing to reduce noise and account for partial volumes around WMH edges. Automatic WMH estimates were visually checked and stroke infarcts masked by a trained image analyst following STRIVE guidelines 22 .
Normal-appearing tissues including cortical grey matter (GM), sub cortical GM, cerebral normal appearing white matter (NAWM) and supratentorial cerebrospinal fluid (CSF) were segmented using population specific tissue probability maps, withinpatient T1 intensity data and adjoining voxel data. Normal appearing tissue segmentations were checked and edited in the same manner as WMH.
Measures of cerebral diffusion included fractional anisotropy (FA) and mean diffusivity (MD) that were calculated from the eigenvalues (magnitude of water movement in each diffusion direction) obtained with diffusion MRI. The BrainSuite Diffusion Pipeline (BDP) 23, 24 corrected geometric distortions in diffusion images and co-registered diffusion and structural images. FA and MD were calculated in regions of WMH and NAWM.
Change in modality of renal replacement therapy
The primary aim of our study is to observe the effect of hemodialysis treatment on cerebral function and structure. However, we acknowledged many patients suitable for recruitment may be listed for renal transplantation. Therefore, patients who 
Statistical Analyses
Baseline demographic variables are presented as medians and compared using Mann-Whitney U or Chi-squared as appropriate.
Primary Analyses
Our primary aim was to describe alterations in cerebral blood flow and correlate this with intradialytic cognitive variation. Thus, mean flow velocity is presented as a 
Power calculations
To assess cognitive function we calculated 73 patients would be required to show that a decline in HD, based on published baseline ranges of a mean rescaled executive function of 8.7 (SD 2.8) 3 and assuming a decline of 1 during follow up, with SD of mean of 3. To allow for 25% drop out, we aimed to recruit 97 patients.
The primary analysis for the MRI study is to detect correlation between TCD and MRI findings as WMH lesion burden. To detect correlation r (r=0.5), using a two-sided test at 5% significance with 80% power, the required sample size is 29. To allow for 25% drop out (death and renal transplant), 40 patients will be recruited.
Results
Ninety seven patients were recruited, median [ [22, 34] days.
Cognitive Impairment at baseline off dialysis
Cognitive impairment was present in 43 (48.9%) of this population who were not known to have cognitive impairment, based on MOCA<26. Demographics are demonstrated in table 1. Those with cognitive impairment were more likely to have evidence of systolic hypertension; pre-dialysis systolic blood pressure 148.8vs 133.5mmHg, p=0.02. There were no differences in age or duration of ESRD. 
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MR derived structural Changes
In those who continued on dialysis, progressive lobar atrophy was evident in frontal, parietal and temporal lobes, p<0.05, table 5. White matter hyperintensity burden increased, 2.96-3.36mL, p=0.018, figure 2. There were no changes in DTI measures, FA and MD, table 5.
Following kidney transplant, a similar pattern of lobar atrophy was noted. However, there was no progression in WMH burden. Fractional anisotropy in white matter increased, 0.28 -0.29, p=0.016, table 5.
Correlating structural changes with cognitive function
There was no correlation between %decline in MFV assessed at baseline and MRI findings.
In those who continue dialysis greater frontal atrophy correlates with worsening score in global cognitive and executive function, MOCA, rho 0.454, p=0.04, TMTBrho 0.620, p=0.01 and auditory-verbal memory, rho 0.805, p=0.01. An increase in WMH burden correlates with verbal fluency and mood, rho 0.585, p=0.01 and rho -0.485, p=0.03, table 6.
In who received a kidney transplant, an increase in WMH burden correlates with worsening executive function, TMTB rho -0.81, p=0.015. In contrast, an increase in fractional anisotropy correlates with an improvement in executive function, LDST rho -0.886, p=0.019. Surprisingly, worsening frontal atrophy correlated with improvement in executive function.
Discussion
This prospective study of people with ESRD encompassing blood flow, functional and structural assessments of the brain has several important findings. Firstly, we demonstrated that cerebral blood flow declines during dialysis, correlating with ultrafiltration volumes and with a measurable decline in executive function. At followup, a correlation was detected between reduced cerebral blood flow and executive function in those who remained on dialysis but not those who were transplanted.
Following transplant, verbal learning and memory improved. Finally, brain MRI revealed progressive WMH burden in those who remain on dialysis, but not those were transplanted. In contrast, after transplantation increased fractional anisotropy of the white matter correlated with improved executive function.
We believe this study supports the hypothesis that hemodialysis may be associated with short-term 'cerebral-stunning' and demonstrates progressive injury in those who remain on dialysis, whereas there is a demonstrable improvement in memory and white matter integrity in those who are transplanted. Early recognition of those at risk may limit this cerebral injury, which appears potentially reversible by transplantation.
Cognitive function in ESRD: incidence and consequences
We have demonstrated in a 'low-risk' HD population, without recorded cerebrovascular disease or cognitive impairment, that mild cognitive impairment is present in 48.9%. Once end-stage renal disease is established, it is estimated that up to 70% of those on HD have cognitive impairment 1 . Surprisingly, in that particular study only ~3% had documentation of cognitive impairment. We demonstrated intradialytic cerebral blood flow declines with increasing ultrafiltration volumes Therefore, in ESRD, failure to recognise cognitive impairment could perpetuate future cognitive decline; due to cognitive impairment patient concordance with fluid restriction is poor , a necessary increase in ultrafiltration volumes compromise cerebral circulation cognition worsens and concordance worsens still. . Morbidity aside, cognitive dysfunction is also associated with all-cause mortality 25, 26 and dialysis withdrawal 27 .
Dialysis and Cognitive Dysfunction
Multiple factors are reported to influence cognitive function in CKD. Conventional risk factors such as age, diabetes, hypertension and dyslipidaemia are abundant however unconventional 'renal' factors including treatments for CKD e.g. the historical effect of aluminium toxicity 28 or more recently the effect of dialysis itself are implicated 2, [29] [30] [31] . In contrast to neurodegenerative cognitive disorders where memory is predominantly affected, the pattern of cognitive impairment most commonly described in those with CKD is loss of executive function 2-4 , a phenotype associated with vascular cognitive impairment. Further, more intensive dialysis does not improve function 6, 7 . This has led to the conclusion that cognitive impairment is driven by cerebrovascular disease.
Previous data on cognitive variation around the dialysis session are conflicting.
Authors have described both improvements 31, 32 and worsening 30 of post dialysis cognition. We believe we are the first study to correlate an acute change in cerebral blood flow with real-time alterations in cognitive function. This has several important implications. Immediately, clinicians should be aware that detailed clinical discussions should not be undertaken during hemodialysis as comprehension and recall maybe affected. Further, this must prompt additional research designed to limit the damage observed on MRI. One clinical trial has demonstrated using dialysate cooling can provides stability in white matter integrity at one year 33 . The beneficial cognitive effects of renal transplantation require further attention and the benefit of expediting transplantation as a treatment for early cognitive dysfunction should not be overlooked.
Transplantation and Cognitive Dysfunction
Renal transplantation remains the 'gold standard' treatment for ESRD 34 .
Transplantation reduces the risk of cardiovascular disease 35 , increasing life expectancy and improves quality of life 36 . In our study we have observed, as others have [37] [38] [39] , an improvement in cognitive function following transplantation, specifically memory albeit in a small cohort of our patients. Fractional anisotropy is a marker of white matter integrity and deficits in diffusion are recognised to precede white matter hyper intensity formation and are associated with worsening executive function 40 . In those who received a renal transplant, FA improved and correlated with improved executive function, whereas there was no demonstrable improvement in anisotropic diffusion in those remaining on hemodialysis. Previous authors have demonstrated improvement in executive function following transplantation 38 , a finding that does not appear to achievable by more frequent dialysis. In an analysis of participants in the Frequent Hemodialysis Network an improvement in auditory-verbal memory and processing speed was observed following transplantation, but not after 12 months of frequent hemodialysis (6 days/week) 7 . This is supportive of a 'side-effect' produced by HD, ameliorated by transplantation.
Limitations
This prospective observational cohort study has demonstrated important findings in a real-world ESRD cohort. However, we recognise the following limitations. As an observational study we cannot prove causation due to inability to account for unmeasured variables. For example, we do not have bicarbonate or blood viscosity levels which may be of greater significance than ultrafiltration volume on MFV. We excluded those with any known evidence of cerebrovascular disease which resulted in a younger cohort. This reduces generalisability and makes it likely we have underestimated the prevalence of cognitive impairment and the impact of ongoing treatments on more 'fragile' brains. Whilst we acknowledge this as a limitation, we also believe this makes our findings all the more striking. No attempts were made to standardise dialysis regimes. Although this could mask findings acutely, we believe Attempts were made to limit a learning effect. Namely, multiple versions of MOCA and HVLT were used, a minimum of 14 days between assessments was allowed and visit order was reversed in a randomly selected 20%. Despite our attempts we cannot completely exclude this learning effect. Frontal atrophy correlated with improved executive function in transplanted patients. Whilst frontal atrophy is a marker of aging, and executive function can improve following transplantation 38 it is important to acknowledge our low number of transplant patients at follow-up, which could introduce both type 1 and 2 errors. In particularthis small number may lead to chance association between MR imaging findings and change in cognitive function. We did not detect correlation between MFV and MRI changes. Only 24 patients completed follow-up scans in 24 patients whilst on continued dialysis. Therefore, correlating %decline MFV with MRI findings is underpowered and may account for the lack of effect. Finally, and with particular reference to the young age of our cohort, we did not detect progressive cognitive dysfunctionrather improvement in MOCA score at 12 months in those on continued dialysis. It is likely that the follow-up time was too short to detect a measurable difference in cognitive function in this recruited cohort.
Conclusions
Our study has highlighted the high frequency of occult cognitive impairment, affecting 50% of our prevalent dialysis cohort without known cerebrovascular disease. Hemodialysis is capable of inducing a transient decline in cerebral blood flow, correlating with intradialytic cognitive dysfunction. Evidence of progressive cerebrovascular disease is demonstrated in those who remain on dialysis, whereas following transplantation improvement in cognitive function and cerebral anisotropic diffusion is suggestive of reversibility. Urgent interventions are required to limit cerebral stunning and prevent progressive cognitive decline.
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